Home > Gastroenterology > Asymptomatic SARS-CoV-2 infection common in IBD patients

Asymptomatic SARS-CoV-2 infection common in IBD patients

Journal
Gastroenterology
Reuters Health - 04/09/2020 - As many as one in five patients with inflammatory bowel disease (IBD) under biologic treatment have evidence of mild or asymptomatic SARS-CoV-2 infection, researchers in Italy report. Patients with IBD, including those on biologic treatment, appear to have an uneventful course during the SARS-CoV-2 pandemic, but the rate of exposure of these patients to SARS-CoV-2 remains unknown. Dr. Lorenzo Norsa and colleagues at Papa Giovanni XXIII Hospital, in Bergamo, assessed the seroprevalence of COVID-19 among all 103 adult and pediatric patients with IBD undergoing biologic therapy at their center during the Italian COVID-19 outbreak. All symptoms suggestive of SARS-CoV-2 infection reported by these patients were mild, and none required hospitalization for COVID-19. Of the 90 patients who underwent serologic testing, 19 (21%) were positive for IgG, IgM, or both, the authors report in Gastroenterology. Eleven of these 19 pa...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on